These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 900867)

  • 21. Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat.
    Fahrenkrug J
    Biochem Biophys Res Commun; 1991 Jul; 178(1):173-7. PubMed ID: 2069556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the immunocytochemical localization of the vasoactive intestinal polypeptide.
    Larsson LI; Polak JM; Buffa R; Sundler F; Solcia E
    J Histochem Cytochem; 1979 May; 27(5):936-8. PubMed ID: 479555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal polypeptide (VIP).
    Miller RJ
    Med Biol; 1980 Aug; 58(4):179-81. PubMed ID: 7266081
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily variations in concentration of vasoactive intestinal polypeptide immunoreactivity in discrete brain areas of the rat.
    Morin A; Denoroy L; Jouvet M
    Brain Res; 1991 Jan; 538(1):136-40. PubMed ID: 2018925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactive somatostatin and vasoactive intestinal peptide in the digestive tract of cats.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gastroenterology; 1980 Nov; 79(5 Pt 1):837-43. PubMed ID: 6106619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide: quantification by radioimmunoassay in isolated cells, mucosa, and muscle of the hamster intestine.
    Gaginella TS; Mekhjian HS; O'Dorisio TM
    Gastroenterology; 1978 Apr; 74(4):718-21. PubMed ID: 631509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [VIP].
    Yamaguchi K; Abe K; Yanaihara N
    Nihon Rinsho; 1979 Jun; Suppl():2296-9. PubMed ID: 491133
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay.
    Németh J; Jakab B; Reglodi D; Lubics A; Józsa R; Hollósy T; Tamás A; Lengvári I; Görcs T; Szolcsányi J
    Regul Pept; 2002 Nov; 109(1-3):3-7. PubMed ID: 12409208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VIP innervation of the gallbladder.
    Sundler F; Alumets J; Håkanson R; Ingemansson S; Fahrenkrug J; Schaffalitzky de Muckadell O
    Gastroenterology; 1977 Jun; 72(6):1375-7. PubMed ID: 858483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VIP (vasoactive intestinal polypeptide)-immunoreactive neurons in the retina of the rat.
    Lorén I; Tornqvist K; Alumets J
    Cell Tissue Res; 1980; 210(1):167-70. PubMed ID: 7407861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of immunoreactive CCK, VIP and secretin in rat brain and gut.
    Ichihara K; Eng J; Yalow RS
    Biochem Biophys Res Commun; 1983 May; 112(3):891-8. PubMed ID: 6847687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal polypeptide in the neurohypophysis [proceedings].
    Van Noorden S; Polak JM; Bloom SR; Bryant MG
    J Endocrinol; 1979 May; 81(2):140P-141P. PubMed ID: 458317
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in anuran intestine.
    Buchan AM; Polak JM; Bryant MG; Bloom SR; Pearse AG
    Cell Tissue Res; 1981; 216(2):413-22. PubMed ID: 6784927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal polypeptide in the pituitary pars nervosa.
    van Noorden S; Polak JM; Bloom SR; Bryant MG
    Neuropathol Appl Neurobiol; 1979; 5(2):149-53. PubMed ID: 471186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat.
    Romualdi P; Rosenberger JG; Gozzini L; Cox BM
    Peptides; 1989; 10(3):621-6. PubMed ID: 2780421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis.
    Roberts GW; Woodhams PL; Bryant MG; Crow TJ; Bloom SR; Polak JM
    Histochemistry; 1980 Feb; 65(2):103-19. PubMed ID: 7358518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.